News

World Cancer Day - unveiling the impact of My Cancer Navigator, a beacon for cancer patients

Ahead of World Cancer Day, we highlight the impact My Cancer Navigator has had in the last five years. Our free information service has been a pillar of support for cancer patients globally.

Rare cancer drug development boosted by international research alliance

The Anticancer Fund is excited to announce a groundbreaking collaboration aimed at advancing the field of rare cancer research, the ATTRACT-initiative. In a pioneering effort, five anti-cancer charities will dedicate 21 million euros to accelerate drug development for rare cancers through cross-border clinical academic research.

podcast en français sur My Cancer Navigator

My Cancer Navigator featured in a podcast by Delphine Rémy

My Cancer Navigator takes center stage in a podcast produced by Delphine Rémy, renowned for her work on ‘Naître princesse, devenir guerrière’. The podcast delves into the core features and benefits of our information service for cancer patients. Listeners will hear from Gilles Van der Spek, who candidly shares his journey and highlights the impact My Cancer Navigator has had on his experience.

A publication by scientists of the Anticancer Fund

Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study

Christoffer Gebhardt, Sonja C S Simon, Rebekka Weber, Mirko Gries, Dong Hun Mun, Raphael Reinhard, Tim Holland-Letz, Viktor Umansky, Jochen Utikal. Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study. Cellular Immunology, 2021 Feb;360:104274, doi: 10.1016/j.cellimm.2020.104274

The MATAO trial for ovarian cancer patients is open for participation

Discovering Darwin in oncology: Launch of a ‘Request for Application’ for researchers in evolutionary therapy